关于公司
PhySoft AMS manages anemia for dialysis patients through an ESA dosing algorithm, improving patient outcomes, while reducing ESA costs and hospitalizations. It recommends a optimum ESA dosage to reach and maintain the Hgb level chosen by the clinician. It optimizes Aranesp dosing, Epogen dosing and Mircera dosing. Helps convert to Mircera.
US
未知
未知
未验证公司
业务透明度
- 未验证公司信息
- 向他们的客户询问评论
- 没有回复负面评论